Literature DB >> 17710405

Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China.

Ruiwen Chen1, Meng Fang, Qing Cai, Shiwei Duan, Ke Lv, Ning Cheng, Daming Ren, Jie Shen, Dongyi He, Lin He, Shuhan Sun.   

Abstract

The aim of this study was to investigate the association of single nucleotide polymorphisms (SNPs) in tumor necrosis factor alpha (TNFalpha) promoter with rheumatoid arthritis (RA) in Chinese Han population. Six SNPs at positions -238, -244, -308, -376, -857, -863 within TNFalpha promoter were genotyped in 367 unrelated RA patients and 271 healthy controls, using direct DNA sequencing method. Allelic, genotypic, and haplotypic associations of these SNPs with RA were examined. The frequencies of TNFalpha -308A allele and the haplotype GACC (in order of -238, -308, -857, -863) were significantly lower in RA patients when compared with healthy controls (P = 0.0046, P = 0.0045, respectively) but TNFalpha -308 polymorphism was not related to the clinical manifestations of RA patients. These results implied that TNFalpha gene itself or a gene in linkage disequilibrium with it might be associated with RA in Han population of Eastern China.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17710405     DOI: 10.1007/s00296-007-0409-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  37 in total

1.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

2.  Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study.

Authors:  D van Zeben; J M Hazes; A H Zwinderman; A Cats; G M Schreuder; J D'Amaro; F C Breedveld
Journal:  Arthritis Rheum       Date:  1991-07

3.  Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.

Authors:  Martina Fabris; Emma Di Poi; Angela D'Elia; Giuseppe Damante; Luigi Sinigaglia; Gianfranco Ferraccioli
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

4.  Polymorphisms in the 5'-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis.

Authors:  N Seki; S Kamizono; A Yamada; T Higuchi; H Matsumoto; F Niiya; A Kimura; K Tsuchiya; R Suzuki; Y Date; T Tomita; K Itoh; T Ochi
Journal:  Tissue Antigens       Date:  1999-08

5.  A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region.

Authors:  M Ota; Y Katsuyama; A Kimura; K Tsuchiya; M Kondo; T Naruse; N Mizuki; K Itoh; T Sasazuki; H Inoko
Journal:  Genomics       Date:  2001-02-01       Impact factor: 5.736

6.  Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-alpha.

Authors:  K Lv; R Chen; Q Cai; M Fang; S Sun
Journal:  Scand J Immunol       Date:  2006-08       Impact factor: 3.487

7.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter.

Authors:  A M Uglialoro; D Turbay; P A Pesavento; J C Delgado; F E McKenzie; J G Gribben; D Hartl; E J Yunis; A E Goldfeld
Journal:  Tissue Antigens       Date:  1998-10

8.  Lack of association of tumor necrosis factor alpha gene polymorphism in patients with rheumatoid arthritis in central Taiwan.

Authors:  Sui-Foo Lo; Chung-Ming Huang; Mei-Chen Wu; Jer-Yuarn Wu; Fuu-Jen Tsai
Journal:  Rheumatol Int       Date:  2003-05-16       Impact factor: 2.631

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  6 in total

1.  Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.

Authors:  Daniel Cadena-Sandoval; Isidro Alemán-Ávila; Rosa Elda Barbosa-Cobos; Lizbeth Teresa Becerril-Mendoza; José Manuel Fragoso; Julián Ramírez-Bello
Journal:  Mol Biol Rep       Date:  2018-02-05       Impact factor: 2.316

2.  No significant association between genetic polymorphisms in the TNAP gene and ankylosing spondylitis in the Chinese Han population.

Authors:  Ning Cheng; Qing Cai; Meng Fang; Shiwei Duan; Jingan Lin; Jianda Hu; Ruiwen Chen; Shuhan Sun
Journal:  Rheumatol Int       Date:  2008-09-04       Impact factor: 2.631

3.  Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.

Authors:  Jelena Basic; Dusica Pavlovic; Tatjana Jevtovic-Stoimenov; Jelena Vojinovic; Gordana Susic; Ivana Stojanovic; Gordana Kocic; Vuk Milosevic; Tatjana Cvetkovic; Milena Marinkovic; Andrej Veljkovic
Journal:  J Physiol Biochem       Date:  2010-07-02       Impact factor: 4.158

4.  The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population.

Authors:  Ruiwen Chen; Yubao Wei; Qing Cai; Shiwei Duan; Daming Ren; Jie Shen; Dongyi He; Meng Fang; Ke Lv; Ning Cheng; Shuhan Sun
Journal:  Rheumatol Int       Date:  2010-06-20       Impact factor: 2.631

5.  TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients.

Authors:  Hannan Al-Rayes; Ramiz Al-Swailem; Maysson Albelawi; Misbahul Arfin; Abdulrahman Al-Asmari; Mohammad Tariq
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-06-14

6.  Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity.

Authors:  Heba M Zaghlol; Sanaa Abdelshafy; Rabab A Mohamed; Enas A Abdelaleem
Journal:  Cent Eur J Immunol       Date:  2019-09-30       Impact factor: 2.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.